NovoCure LimitedNVCRNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P42
Within normal range
vs 5Y Ago
-2.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -20.01% | -10.5% |
| 2024 | -18.11% | +48.0% |
| 2023 | -34.84% | -176.0% |
| 2022 | -12.62% | -75.9% |
| 2021 | -7.17% | -179.1% |
| 2020 | 9.07% | +137.0% |
| 2019 | 3.83% | +140.5% |
| 2018 | -9.45% | +42.6% |
| 2017 | -16.45% | +87.5% |
| 2016 | -131.37% | - |